APOB and metabolic syndrome: Consistent with metabolic syndrome profiles, the high‐VAT group exhibited significantly elevated CVD risk markers: older age (mean difference: +9.0 years, 41.53 ± 10.77 vs. 32.55 ± 10.64 years, p < 0.001), greater WC (+21.4 cm, 10.32 ± 1.45 vs. 8.18 ± 0.99 cm, p < 0.001), higher BMI (30.83 ± 6.48 vs. 23.32 ± 4.16 kg/m2, p < 0.001), and adverse lipid profiles including TG (1.52 ± 1.16 vs. 0.87 ± 0.50 mmol/L, p < 0.001) and ApoB (0.96 ± 0.25 vs. 0.77 ± 0.20 g/L, p < 0.001).